Cargando…

cmFPA008, an anti-mouse CSF-1R antibody, combines with multiple immunotherapies to reduce tumor growth in nonclinical models

Detalles Bibliográficos
Autores principales: Bellovin, David, Wondyfraw, Nebiyu, Levin, Anita, DeNardo, David G, Masteller, Emma, Brennan, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4649457/
http://dx.doi.org/10.1186/2051-1426-3-S2-P351
_version_ 1782401362165760000
author Bellovin, David
Wondyfraw, Nebiyu
Levin, Anita
DeNardo, David G
Masteller, Emma
Brennan, Thomas
author_facet Bellovin, David
Wondyfraw, Nebiyu
Levin, Anita
DeNardo, David G
Masteller, Emma
Brennan, Thomas
author_sort Bellovin, David
collection PubMed
description
format Online
Article
Text
id pubmed-4649457
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-46494572015-11-24 cmFPA008, an anti-mouse CSF-1R antibody, combines with multiple immunotherapies to reduce tumor growth in nonclinical models Bellovin, David Wondyfraw, Nebiyu Levin, Anita DeNardo, David G Masteller, Emma Brennan, Thomas J Immunother Cancer Poster Presentation BioMed Central 2015-11-04 /pmc/articles/PMC4649457/ http://dx.doi.org/10.1186/2051-1426-3-S2-P351 Text en Copyright © 2015 Bellovin et al. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Poster Presentation
Bellovin, David
Wondyfraw, Nebiyu
Levin, Anita
DeNardo, David G
Masteller, Emma
Brennan, Thomas
cmFPA008, an anti-mouse CSF-1R antibody, combines with multiple immunotherapies to reduce tumor growth in nonclinical models
title cmFPA008, an anti-mouse CSF-1R antibody, combines with multiple immunotherapies to reduce tumor growth in nonclinical models
title_full cmFPA008, an anti-mouse CSF-1R antibody, combines with multiple immunotherapies to reduce tumor growth in nonclinical models
title_fullStr cmFPA008, an anti-mouse CSF-1R antibody, combines with multiple immunotherapies to reduce tumor growth in nonclinical models
title_full_unstemmed cmFPA008, an anti-mouse CSF-1R antibody, combines with multiple immunotherapies to reduce tumor growth in nonclinical models
title_short cmFPA008, an anti-mouse CSF-1R antibody, combines with multiple immunotherapies to reduce tumor growth in nonclinical models
title_sort cmfpa008, an anti-mouse csf-1r antibody, combines with multiple immunotherapies to reduce tumor growth in nonclinical models
topic Poster Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4649457/
http://dx.doi.org/10.1186/2051-1426-3-S2-P351
work_keys_str_mv AT bellovindavid cmfpa008anantimousecsf1rantibodycombineswithmultipleimmunotherapiestoreducetumorgrowthinnonclinicalmodels
AT wondyfrawnebiyu cmfpa008anantimousecsf1rantibodycombineswithmultipleimmunotherapiestoreducetumorgrowthinnonclinicalmodels
AT levinanita cmfpa008anantimousecsf1rantibodycombineswithmultipleimmunotherapiestoreducetumorgrowthinnonclinicalmodels
AT denardodavidg cmfpa008anantimousecsf1rantibodycombineswithmultipleimmunotherapiestoreducetumorgrowthinnonclinicalmodels
AT mastelleremma cmfpa008anantimousecsf1rantibodycombineswithmultipleimmunotherapiestoreducetumorgrowthinnonclinicalmodels
AT brennanthomas cmfpa008anantimousecsf1rantibodycombineswithmultipleimmunotherapiestoreducetumorgrowthinnonclinicalmodels